Could regulating MDMA make it safer?
Given MDMA’s popularity, potential therapeutic uses, and low harm profile, is it time we re-examine how we regulate it here? Drug Foundation Senior Communications Advisor Feilidh Dwyer investigates.
NZ Drug Foundation Lived and Living Experience Forum: Pae Ora - Our Health 2023
Join the NZ Drug Foundation's Lived & Living Experience Forum: Pae Ora - Our Health. Connect, learn, & collaborate to improve hauora needs.
NZ Drug Foundation Parliamentary Symposium 2023
Join the 2023 NZ Drug Foundation Symposium to address health needs, explore psychedelics, and discuss overdose prevention in Aotearoa.
A Psychedelic Renaissance? 'Blue Honey' and what's next for psilocybin in Aotearoa
In Aotearoa, scientists, iwi, as well as hobbyists and amateurs are busy researching what psilocybin’s potential could be. So, what’s next for psilocybin in Aotearoa?
The Tairāwhiti hapū exploring indigenous psilocybin to treat methamphetamine addiction
A hāpori (community) from Rangiwaho marae in Tairāwhiti Gisborne is embarking on a ground-breaking study that will explore using the indigenous Psilocybe weraroa fungus as a potential treatment for members of their community dealing with me
Report: What we found at drug checking in 2022
Our findings from our first full year as a licensed drug checking provider.
Your thoughts needed: Join our addictions workforce workshops
What Australia's surprise MDMA and psilocybin move means
Russell Brown takes a look at how Australia's recent move to allow psilocybin and MDMA for prescription would work in practice, and whether a similar shift could be possible in New Zealand.
Drug Foundation warns some LSD circulating is more dangerous drug
Drug checking services at Rhythm and Vines found potent psychedelic and stimulant, 25B-NBOH, sold as tabs of LSD.